Cyclopropyl-(5-nitro-pyridin-2-yl)-amine, 95.0%, 1g

tert-Butyl (3S,4S)-3-amino-4-fluoropiperidine-1-carboxylate, 97%, 250mg

(2E)-3-(4-tert-butylphenyl)-1-(4-ethylphenyl)prop-2-en-1-one, 95.0%, 2g

2-(2-Bromo-4,5-difluorophenyl)acetic acid, 95.0%, 250mg

(S)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-(((benzyloxy)carbonyl)amino)butanoic acid, 98%, 250mg

(R)-tert-Butyl 3-acetamidopiperidine-1-carboxylate, 1g

4,5-Dihydroxyimidazolidin-2-one>98.0%(T)200mg

Methyl-(4-methyl-benzyl)-piperidin-3-yl-amine hydrochloride, 95.0%, 100mg

Dimethyl 2-propyl-1H-imidazole-4,5-dicarboxylate, 95.0%, 5g

4-(Bromomethyl)-1-methyl-1H-pyrazole hydrobromide, 95.0%, 25g

1-(2-Methoxyethyl)-5-oxopyrrolidine-3-carboxylic acid, 95.0%, 5g

3-CHLORO-2-METHYL-6-(TRIFLUOROMETHYL)QUINOXALINE, 95%, 250mg

1-(4-Chlorophenyl)-1-methylethylamine hydrochloride, 95.0%, 1g